A trend toward significance was also observed for a lower proportion of patients with moderate to marked hyperemia (Power Doppler grade 2 and 3) upon rituximab (5/32, 15.6% vs. 15/44, 34.1%, P = 0.072).
← all excerpts
Linking systemic angiogenic markers to synovial vascularization in rheumatoid arthritis.
1
—
—